Syndax Pharmaceuticals, Inc.
SNDX
$19.84
$0.763.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 34.10% | 26.56% | 10.46% | -4.89% | -26.85% |
| Total Depreciation and Amortization | 650.00% | 100.00% | -25.00% | -72.73% | -83.33% |
| Total Amortization of Deferred Charges | 113.20% | 21.13% | 660.00% | -- | -- |
| Total Other Non-Cash Items | 34.54% | 42.26% | 35.94% | 56.40% | 67.21% |
| Change in Net Operating Assets | -1,031.99% | -757.37% | -697.72% | -433.83% | -514.04% |
| Cash from Operations | 27.10% | 2.92% | -17.49% | -20.09% | -25.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 481.17% | 993.77% | 232.05% | -283.49% | -232.54% |
| Cash from Investing | 480.68% | 993.05% | 231.97% | -283.89% | -232.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 247.64% | 143.77% | 40.77% | -95.64% | -96.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -22.48% | -94.13% | -96.13% | 34.32% | 33.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6,928.58% | -158.95% | 86.36% | -142.14% | -60.10% |